(Q34275641)

1 August 2017

1 reference

title

Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic (English)

1 reference

1 August 2017

Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to Clinic (English)

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

30 March 2024

author name string

Ivana Vucenik

1

1 reference

1 August 2017

AbulKalam M. Shamsuddin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608114

30 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

1 August 2017

https://academic.oup.com/jn/article-pdf/133/11/3778S/24018517/3778s.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608114

http://jn.nutrition.org/cgi/content/abstract/133/11_suppl_1/3778S

30 March 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608114

https://api.elsevier.com/content/article/PII:S002231662302535X?httpAccept=text/xml

30 March 2024

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

https://api.elsevier.com/content/article/PII:S002231662302535X?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

http://academic.oup.com/jn/article-pdf/133/11/3778S/24018517/3778s.pdf

30 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

30 March 2024

1 reference

1 August 2017

volume

133

1 reference

1 August 2017

issue

11 Suppl 1

1 reference

1 August 2017

page(s)

3778S-3784S

1 reference

1 August 2017

cites work

Cancer statistics, 2003.

1

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Progress in clinical chemoprevention

30 March 2024

2

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

IP6: a novel anti-cancer agent

30 March 2024

4

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol phosphates have novel anticancer function

30 March 2024

5

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Phytates in Legumes and Cereals

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol phosphates and cell signalling

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol phosphates and cell signaling: new views of InsP5 and InsP6.

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Antioxidant functions of phytic acid

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inhibition of Phosphatases and Increased Ca2+ Channel Activity by Inositol Hexakisphosphate

30 March 2024

14

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells.

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated exocytosis of insulin by activation of protein kinase C

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate.

30 March 2024

18

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexaphosphate inhibits large intestinal cancer in F344 rats 5 months after induction by azoxymethane.

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

[3H]inositol hexaphosphate (phytic acid) is rapidly absorbed and metabolized by murine and human malignant cells in vitro.

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

[3H]phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Absorption and excretion of orally administered inositol hexaphosphate (IP(6) or phytate) in humans

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Effects of exogenous inositol hexakisphosphate (InsP(6)) on the levels of InsP(6) and of inositol trisphosphate (InsP(3)) in malignant cells, tissues and biological fluids

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFkappaB-mediated cell survival pathway

30 March 2024

25

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Effect of inositol hexaphosphate (IP(6)) on human normal and leukaemic haematopoietic cells

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid)

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells

30 March 2024

33

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes

30 March 2024

34

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexaphosphate reduces 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase independent of protein kinase C isoform expression in keratinocytes

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Comparative cytotoxicities of selected minor dietary non-nutrients with chemopreventive properties

30 March 2024

37

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Antitumor activity of phytic acid (inositol hexaphosphate) in murine transplanted and metastatic fibrosarcoma, a pilot study

30 March 2024

39

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats

30 March 2024

40

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

A rapid dual organ rat carcinogenesis bioassay for evaluating the chemoprevention of breast and colon cancer.

30 March 2024

42

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate

30 March 2024

43

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea

30 March 2024

44

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Phytic acid and minerals: effect on early markers of risk for mammary and colon carcinogenesis

30 March 2024

46

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model

30 March 2024

47

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice

30 March 2024

48

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice

30 March 2024

49

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study

30 March 2024

51

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer.

30 March 2024

52

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis.

30 March 2024

53

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene

30 March 2024

54

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression

30 March 2024

59

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Studies in human mineral metabolism: 1. The effect of bread rich in phytate phosphorus on the metabolism of certain mineral salts with special reference to calcium

30 March 2024

60

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Mineral metabolism on rice diets

30 March 2024

61

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

A high oat-bran intake does not impair zinc absorption in humans when added to a low-fiber animal protein-based diet

30 March 2024

63

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

30 March 2024

Idiopathic hypercaicuria

64

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Effects of phytic acid on renal stone formation in rats

30 March 2024

65

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer

30 March 2024

67

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Effect of dietary sodium phytate on the hepatic and serum levels of lipids and on the hepatic activities of NADPH-generating enzymes in rats fed on sucrose

30 March 2024

75

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Modulatory influence of arecoline on the phytic acid-altered hepatic biotransformation system enzymes, sulfhydryl content and lipid peroxidation in a murine system.

30 March 2024

77

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Rice Bran Treatment for Patients with Hypercalciuric Stones: Experimental and Clinical Studies

30 March 2024

79

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Urinary phytate in calcium oxalate stone formers and healthy people--dietary effects on phytate excretion

30 March 2024

80

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant

30 March 2024

83

1 reference

https://api.crossref.org/works/10.1093/JN/133.11.3778S

30 March 2024

Identifiers

0 references

1 reference